NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com

Posted by Trevor Kearing on Aug 3rd, 2024

StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note released on Wednesday morning. The firm issued a sell rating on the medical device company’s stock.

NeuroMetrix Stock Down 2.3 %

Shares of NURO opened at $3.45 on Wednesday. The company has a 50-day simple moving average of $3.72 and a 200-day simple moving average of $3.75. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $7.30.

NeuroMetrix (NASDAQ:NURO – Get Free Report) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%. The firm had revenue of $1.09 million during the quarter.

Institutional Investors Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC acquired a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned 2.80% of NeuroMetrix as of its most recent filing with the Securities and Exchange Commission. 19.40% of the stock is owned by institutional investors.

NeuroMetrix Company Profile

(Get Free Report)

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.